How many employees does Savara have this year?
Savara has 42 undefined employees this year.
Savara Employees 2025
Savara Employees
42
Ticker
SVRA
ISIN
US8051111016
WKN
A2DQ2B
In 2025, Savara employed 42 people, a 0% change from the 42 number of employees in the previous year.
Savara Aktienanalyse
What does Savara do?
Savara Inc is a US biotechnology company specializing in the development and commercialization of therapies for rare respiratory diseases. The company was founded in 2007 and is headquartered in Austin, Texas. Savara initially focused on treating cystic fibrosis, a genetic disease that can cause severe lung problems. The company developed an innovative therapy based on the use of liposomes, tiny bubbles that can deliver medication directly to the lungs. This method was considered promising and received orphan drug status from the FDA, meaning it is intended for the treatment of rare diseases. However, due to high costs associated with developing and approving a new medication for cystic fibrosis, Savara decided to redefine its goals and focus on other rare respiratory diseases. The company's business model is based on identifying promising therapy approaches for these diseases and developing them into approvable medications. Savara collaborates closely with leading experts and scientists in the field of respiratory diseases. Its main therapy areas include cystic fibrosis, pulmonary fibrosis, and rare lung diseases. Savara has a special focus on developing liposome-based therapies, which have the potential to target the affected areas in the lungs and enhance the effects of other medications. Currently, the company offers three products: - AeroVanc: A liposome-based inhaled antibiotic used to treat cystic fibrosis-induced chronic lung infections. AeroVanc is the first FDA-approved medication in Savara's history. - Molgradex: A recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) being developed for the treatment of autoimmune pulmonary alveolitis (also known as extrinsic allergic alveolitis). - AVAIL: A liposome-based inhaled antibiotic currently in Phase II of clinical development, being developed to treat non-tuberculous mycobacterial (NTM) lung infections. Savara has also formed partnerships with other companies and organizations to advance its research and development. Partners include the Cystic Fibrosis Foundation, the National Institutes of Health (NIH), and the European Respiratory Society. In summary, Savara Inc is a biotechnology company focused on developing therapies for rare respiratory diseases. The company has developed a promising technology platform and collaborates closely with leading experts and scientists in the field. Savara has a range of products on the market, including the first FDA-approved medication in the company's history. Savara ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Savara's Employee Base
Savara's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Savara's operational capacity and future potential.
Year-to-Year Comparison
Assessing Savara's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Savara's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Savara’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Savara stock
How many employees did Savara have compared to the previous year?
Compared to the previous year, Savara had 0% more employees.
What impact did the number of employees have on the company Savara?
The number of employees has a direct impact on the efficiency and productivity of Savara. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Savara?
The number of employees can also have an impact on investors of Savara, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Savara affect the company?
An increase in equity of Savara can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Savara's equity affect the company?
A reduction in equity of Savara can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Savara?
Some factors that can influence the equity of Savara include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Savara so important for investors?
The equity of Savara is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Savara influence the company?
The number of employees at Savara can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Savara evolved in recent years?
In recent years, the number of employees at Savara has changed by 0.
How many employees does Savara currently have?
Savara currently has 42 undefined employees.
Why is the number of employees important for investors of Savara?
The number of employees is important for investors of Savara as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Savara take to change the number of employees?
To change the number of employees, Savara can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Savara pay?
Over the past 12 months, Savara paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Savara is expected to pay a dividend of 0 USD.
What is the dividend yield of Savara?
The current dividend yield of Savara is .
When does Savara pay dividends?
Savara pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Savara?
Savara paid dividends every year for the past 0 years.
What is the dividend of Savara?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Savara located?
Savara is assigned to the 'Health' sector.
Wann musste ich die Aktien von Savara kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Savara from 6/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/28/2025.
When did Savara pay the last dividend?
The last dividend was paid out on 6/28/2025.
What was the dividend of Savara in the year 2024?
In the year 2024, Savara distributed 0 USD as dividends.
In which currency does Savara pay out the dividend?
The dividends of Savara are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Savara
Our stock analysis for Savara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Savara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
